Headache medication and the COVID-19 pandemic
Identifieur interne : 000462 ( Main/Merge ); précédent : 000461; suivant : 000463Headache medication and the COVID-19 pandemic
Auteurs : Antoinette Maassenvandenbrink ; Tessa De Vries ; A. H. Jan DanserSource :
- The Journal of Headache and Pain [ 1129-2369 ] ; 2020.
Abstract
The world is currently dominated by the Corona Virus Disease 2019 (COVID-19) pandemic. Besides the obvious concerns about limitation of virus spread and providing the best possible care to infected patients, a concomitant concern has now arisen in view of a putative link between the use of certain drugs, such as Renin-Angiotensin System (RAS) inhibitors and ibuprofen, and an increased risk for COVID-19 infection. We here discuss this concern in relation to headache treatment and conclude that, based on current evidence, there is no reason to abandon treatment of headache patients with RAS inhibitors or ibuprofen.
Url:
DOI: 10.1186/s10194-020-01106-5
PubMed: 32334535
PubMed Central: 7183387
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000091
- to stream Pmc, to step Curation: 000091
- to stream Pmc, to step Checkpoint: 000390
- to stream Ncbi, to step Merge: 001034
- to stream Ncbi, to step Curation: 001034
- to stream Ncbi, to step Checkpoint: 001034
Links to Exploration step
PMC:7183387Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Headache medication and the COVID-19 pandemic</title><author><name sortKey="Maassenvandenbrink, Antoinette" sort="Maassenvandenbrink, Antoinette" uniqKey="Maassenvandenbrink A" first="Antoinette" last="Maassenvandenbrink">Antoinette Maassenvandenbrink</name><affiliation><nlm:aff id="Aff1"></nlm:aff></affiliation></author><author><name sortKey="De Vries, Tessa" sort="De Vries, Tessa" uniqKey="De Vries T" first="Tessa" last="De Vries">Tessa De Vries</name><affiliation><nlm:aff id="Aff1"></nlm:aff></affiliation></author><author><name sortKey="Danser, A H Jan" sort="Danser, A H Jan" uniqKey="Danser A" first="A. H. Jan" last="Danser">A. H. Jan Danser</name><affiliation><nlm:aff id="Aff1"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32334535</idno><idno type="pmc">7183387</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183387</idno><idno type="RBID">PMC:7183387</idno><idno type="doi">10.1186/s10194-020-01106-5</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000091</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000091</idno><idno type="wicri:Area/Pmc/Curation">000091</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000091</idno><idno type="wicri:Area/Pmc/Checkpoint">000390</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000390</idno><idno type="wicri:Area/Ncbi/Merge">001034</idno><idno type="wicri:Area/Ncbi/Curation">001034</idno><idno type="wicri:Area/Ncbi/Checkpoint">001034</idno><idno type="wicri:doubleKey">1129-2369:2020:Maassenvandenbrink A:headache:medication:and</idno><idno type="wicri:Area/Main/Merge">000462</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Headache medication and the COVID-19 pandemic</title><author><name sortKey="Maassenvandenbrink, Antoinette" sort="Maassenvandenbrink, Antoinette" uniqKey="Maassenvandenbrink A" first="Antoinette" last="Maassenvandenbrink">Antoinette Maassenvandenbrink</name><affiliation><nlm:aff id="Aff1"></nlm:aff></affiliation></author><author><name sortKey="De Vries, Tessa" sort="De Vries, Tessa" uniqKey="De Vries T" first="Tessa" last="De Vries">Tessa De Vries</name><affiliation><nlm:aff id="Aff1"></nlm:aff></affiliation></author><author><name sortKey="Danser, A H Jan" sort="Danser, A H Jan" uniqKey="Danser A" first="A. H. Jan" last="Danser">A. H. Jan Danser</name><affiliation><nlm:aff id="Aff1"></nlm:aff></affiliation></author></analytic><series><title level="j">The Journal of Headache and Pain</title><idno type="ISSN">1129-2369</idno><idno type="eISSN">1129-2377</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="Par1">The world is currently dominated by the Corona Virus Disease 2019 (COVID-19) pandemic. Besides the obvious concerns about limitation of virus spread and providing the best possible care to infected patients, a concomitant concern has now arisen in view of a putative link between the use of certain drugs, such as Renin-Angiotensin System (RAS) inhibitors and ibuprofen, and an increased risk for COVID-19 infection. We here discuss this concern in relation to headache treatment and conclude that, based on current evidence, there is no reason to abandon treatment of headache patients with RAS inhibitors or ibuprofen.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Fang, L" uniqKey="Fang L">L Fang</name></author><author><name sortKey="Karakiulakis, G" uniqKey="Karakiulakis G">G Karakiulakis</name></author><author><name sortKey="Roth, M" uniqKey="Roth M">M Roth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, W" uniqKey="Li W">W Li</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Loder, E" uniqKey="Loder E">E Loder</name></author><author><name sortKey="Rizzoli, P" uniqKey="Rizzoli P">P Rizzoli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shamliyan, Ta" uniqKey="Shamliyan T">TA Shamliyan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pomes, Lm" uniqKey="Pomes L">LM Pomes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Serfozo, P" uniqKey="Serfozo P">P Serfozo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Arendse, Lb" uniqKey="Arendse L">LB Arendse</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ferrario, Cm" uniqKey="Ferrario C">CM Ferrario</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Wang, X" uniqKey="Wang X">X Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kurth, T" uniqKey="Kurth T">T Kurth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Qiao, W" uniqKey="Qiao W">W Qiao</name></author></analytic></biblStruct></listBibl></div1></back></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000462 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000462 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Merge
|type= RBID
|clé= PMC:7183387
|texte= Headache medication and the COVID-19 pandemic
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:32334535" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |